BIOMAT Database Logo BIOMAT Database Logo

Isolation of antibiotics from a species of Cephalosporium; cephalosporins P1, P2, P3, P4, and P5. 1951

H S BURTON, and E P ABRAHAM

UI MeSH Term Description Entries
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000164 Acremonium A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus. Cephalosporium,Acremoniums,Cephalosporiums
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016272 Occupational Health The promotion and maintenance of physical and mental health in the work environment. Employee Health,Industrial Health,Industrial Hygiene,Occupational Safety,Health, Industrial,Hygiene, Industrial,Safety, Occupational,Health, Employee,Health, Occupational

Related Publications

H S BURTON, and E P ABRAHAM
P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.
April 1997, Proceedings of the National Academy of Sciences of the United States of America,
H S BURTON, and E P ABRAHAM
Synthesis of novel mRNA 5' cap-analogues: dinucleoside P1, P3-tri-, P1, P4-tetra-, and P1, P5-pentaphosphates.
January 2003, Nucleosides, nucleotides & nucleic acids,
H S BURTON, and E P ABRAHAM
Nonmetal-mediated fragmentation of P4: isolation of P1 and P2 bis(carbene) adducts.
January 2009, Angewandte Chemie (International ed. in English),
H S BURTON, and E P ABRAHAM
New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
October 2005, Chemical & pharmaceutical bulletin,
H S BURTON, and E P ABRAHAM
One-pot carbanionic synthesis of P1,P2-diglycosyl, P1,P1,P2-triglycosyl, and P1,P1,P2,P2-tetraribosyl methylenediphosphonates.
October 2006, The Journal of organic chemistry,
H S BURTON, and E P ABRAHAM
Determination of the P1', P2' and P3' subsite-specificity of factor Xa.
February 2003, The international journal of biochemistry & cell biology,
H S BURTON, and E P ABRAHAM
Synthetic strategies to bicyclic tetraphosphanes using P1, P2 and P4 building blocks.
February 2016, Dalton transactions (Cambridge, England : 2003),
H S BURTON, and E P ABRAHAM
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.
October 2004, Bioorganic & medicinal chemistry letters,
H S BURTON, and E P ABRAHAM
Promoters P3, Pa/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance.
December 2002, Antimicrobial agents and chemotherapy,
H S BURTON, and E P ABRAHAM
Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
April 2000, The Biochemical journal,
Copied contents to your clipboard!